Scientific Program
Welcome to the seminal edition of the Medical Aesthetic Injectable Summit (MAIS) to take place at the Palacio de Congresos of beautiful Marbella in Spain from October 4-5, 2024.
This two-day international Summit aims at casting a light on the essential and realistic facets of aesthetic medicine and plastic surgery evolution in injectables.
Day one delves deep into the implications of neuromodulators and neurostimulators, while day two is dedicated to the exploration of all dermal fillers and biostimulators.
Day 1 - NeuromodulatorsRoom 1
Day 1 - NeuromodulatorsRoom 2
Day 2 - FillersRoom 1
Day 2 - FillersRoom 2
Day 1 - NeuromodulatorsRoom 1
Click on the session below to see the agenda:
- Session 1 – Deep Basic Science – Back to the Future
- Session 2 – Product Analysis
- Session 3 – Disruptive Innovations in Toxins & Injection Tools Startups
- Session 4 – Competitive Landscape
- Session 5 – Emerging and Pipeline Technologies in AI for injectables
- Session 6 – Regulatory strategy and Investment Dynamics in Medical Aesthetic Injectables
Day 1 - NeuromodulatorsRoom 2
Click on the session below to see the agenda:
Day 2 - FillersRoom 1
Click on the session below to see the agenda:
- Session 14 – Deep Basic Science – Back to the Future
- Session 15 – Product Analysis
- Session 16 – Disruptive Innovations in Fillers Startups
- Session 17 – Competitive Landscape
- Session 18 – Emerging and Pipeline technologies or Indication in Fillers & Toxins
- Session 19 – Injectable fireside chat
- Session 20 – MAIS Injectables Creator Awards
Day 2 - FillersRoom 2
Program Agenda - Preliminary
Day 1 – Neuromodulators |
|---|
Time | Room 1 | Time | Room 2 | ||
|---|---|---|---|---|---|
07:30 – 09:00 | Registration | ||||
09:00 – 10:15 | Session 1
Deep Basic Science – Back to the Future | 09:30 – 10:15 | Session 8
Open communication – Industry & Toxins | ||
Chair(s): Fauad Hasan, Prof. Mark Nestor, Prof. Bal Ram Singh | Chair(s): Dr. Sergio Escobar, Dr. Khaled Othman | ||||
09:00 – 09:05 | Introduction Fauad Hasan | ||||
09:05 – 09:20 | Does the MoA/Structure of various BoNTs effect their applications in aesthetics?
Prof. Marco Pirazzini | 09:30 – 09:40 | JUVAPLUS – Game changer in toxin injection: Juvapen?
Bernard-Pierre Legrand, CEO and Founder | ||
09:20 – 09:35 | Structure-based engineering of BoNTs
Prof. Rong Sheng Jin | 09:40 – 09:50 | MAHUT – How to support the skin after injectable treatments: The Cosmeclinical approach
Dr. Marina Landau | ||
09:35 – 09:50 | From lab to clinics: some aspects of translational research
Prof. Dirk Dressler | 09:50 – 10:00 | Aller-Tox – the use of Botulinum toxin type A for idiopathic & allergic rhinitis
Ruth Crofford | ||
09:50 – 10:05 | Concepts (Big picture – future direction) – will this be a reality one day?
Prof. Bal Ram Singh | 10:00 – 10:10 | Neurotoxin Therapy in Facial Rehabilitation: The Convergence of Occlusion and Facial Nerve Dynamics
Dr. Siddiqi Komal Ayah | ||
10:10 – 10:15 | Q&A | 10:00 – 10:15 | Q&A | ||
10:15 – 10:45 | COFFEE BREAK | ||||
10:45 – 12:00 | Session 2Product Analysis | 10:45 – 12:00 | Session 9Laboratoires Vivacy SymposiumSTYLAGE® Unveiled: Beyond Basic Fillers – Exploring Hyaluronic Acid’s Cellular Interactions and Clinical Impact |
|---|---|---|---|
Chair(s): Dr. Marina Landau, Dr. Won Lee | Moderator(s): Dr. Benjamin Ascher | ||
10:45 – 11:00 | Presentation of the comparative study
Dr. Marina Landau, Dr. Won Lee | 10:45 – 11:05 | HA Receptor mediated cellular interactions and potential clinical consequences
Prof. Glenn Prestwich |
11:00 – 12:00 | – Round table discussion – | 11:05 – 11:25 | HA is still the best filling material for facial rejuvenation
Dr. Nimrod Friedman |
Rui Avelar, CMO, EVOLUS | 11:25 – 11:45 | STYLAGE® Hydromax: targeted actions on vital skin functions
Denis Couchourel, PhD, Scientific & Medical Director | |
Xiaoming Lin, CMO, GALDERMA | 11:45 – 12:00 | Q&A | |
Dr. Hyoung Jin Moon, CEO & CMO, HUGEL
| |||
Dr. Terri Phillips, Chief Medical Affairs Officer, MERZ AESTHETICS
| |||
Sebastien Malaise, Research & Development Manager, SINCLAIR
|
12:00 – 13:15 | Session 3Disruptive Innovations in Toxins & Injection Tools– Startups – | 12:00 – 13:15 | Session 10HTL Biotechnology SymposiumPioneering Medical Aesthetics: Unlocking the Potential of Biopolymers |
|---|---|---|---|
Chair(s): Humberto Antunes, Fauad Hasan, Prof. Bal Ram Singh | |||
12:00 – 12:05 | Introduction
Humberto Antunes, Fauad Hasan, Prof. Bal Ram Singh, | 12:00 – 12:10 | Driving Innovation: How R&D Shapes HTL Biotechnology’s Future
Anne-Laure Gaudry, Chief Innovation and R&D |
12:05 – 12:29 | Part 1 – Toxins startups | 12:10 – 12:25 | Polynucleotides : From Present Insights to Future Breakthroughs
Mélanie Leroux, Innovation Project Manager |
12:05 – 12:13 | FASTOX – Toxin Enhancer – how will change the current dynamics in aesthetics?
Dr. Philippe Picaut, Pre-clinical, clinical and regulatory | 12:25 – 12:40 | rhCOL3: The Future of Collagen Innovation
Lixin Dai, Senior Director, Biotechnology Innovation |
12:13 – 12:21 | EIRION THERAPEUTICS – Topical formulation – what’s new?
Jon Edelson, CEO | 12:40 – 12:55 | Regenerative Medicine: The Latest Advances in Hyaluronic Acid?
Pr Pierre Weiss, Head of the INSERM Laboratory |
12:21 – 12:29 | REVIVOX – A reversal agent to resolve iatrogenic complications from botulinum neuromodulator procedures
Mary Gardner, CEO | 12:55 – 13:00 | Emerging Opportunities: Defining the Future of medical aesthetics
Anne-Laure Gaudry, Chief Innovation and R&D |
12:29 – 12:53 | Part 2 – Injection Tools startups | 13:00 – 13:15 | Q&A |
12:29 – 12:37 | ARTERY3D – Visualising the individual arterial anatomy of the face through augmented reality
Dr. Marc Mespreuve, Co-founder | ||
12:37 – 12:45 | KOLORPEN – Needle free injection device
Dr. Yoram Eshel, CEO | ||
12:43 – 12:53 | SYRENGY – Smart syringe for double and safe facial aesthetic injections
Dr. Michael Gold | ||
13:09 – 13:15 | Q&A | ||
13:15 – 14:30 | LUNCH | ||
14:30 – 15:45 | Session 4Competitive Landscape | 14:30 – 15:30 | Session 11From Battle to Consensus – Part 1A |
|---|---|---|---|
Chair(s): Laurent Brones, Fauad Hasan, Prof. Mark Nestor | Chair(s): Dr. Marina Landau
Commentators: Dr. Benjamin Ascher, Prof. Haiyan Cui, Dr. Sergio Escobar, Dr. Nimrod Friedman | ||
14:30 – 14:40 | Intro to the market – Quantitative and Qualitative aspect
Raghav Tangri, CETAS HEALTHCARE | 14:30 – 15:00 | Is faster onset or longer duration more important?
a. faster onset – Dr. Patricia Ogilvie
b. longer duration – Dr. Khaled Othman |
14:40 – 14:50 | Wall Street perspective on the market
Vamil Divan, GUGGENHEIM | 15:00 – 15:30 | Why did my BTXA injection fail?
a. Immunogenecity (antibodies) – Dr. Jeremy Green
b. All the rest – Dr. Marina Landau |
14:50 – 15:35 | – Round table discussion – | ||
Maria Cudeiro, General Manager, EVOLUS | |||
Dr. Hyoung Jin Moon, CEO & CMO, HUGEL | |||
Jonathan Parrish, Chief Corporate Development Officer, MERZ AESTHETICS | |||
TBC, SINCLAIR | |||
15:35 – 15:45 | Q&A |
15:45 – 17:00 | Session 5Emerging and Pipeline Technologies in AI for Injectables | 15:30 – 17:00 | Session 12From Battle to Consensus – Part 1B |
|---|---|---|---|
Chair(s): Dr. Jeremy Green, Dr. Diala Haykal | Chair(s): Dr. Marina Landau
Commentators: Dr. Benjamin Ascher, Prof. Haiyan Cui, Dr. Sergio Escobar, Dr. Nimrod Friedman | ||
15:45 – 15:57 | Fillers treatments optimized by AI
Dr. Diala Haykal | 15:30 – 16:00 | Diluting toxin
a. Yes – Dr. Frank Rosengaus
b. No – Dr. Pierre Andre |
15:57 – 16:09 | CAARISMA MED – AI Assistance in Aesthetic Medicine – Objectifying Aesthetics for Medical Providers and Patients
Dr. Rainer Pooth | 16:00 – 16:30 | Do liquid toxins have a real advantage?
a. yes – Dr. Michael Gold, Dr. Patricia Ogilvie
b. No – Dr. Benjamin Ascher |
16:09 – 16:21 | Potentials of AI in Aesthetic Injectables in Asia: Automation
Dr. Ting Song Lim | 16:30 – 17:00 | Will new technology bring additional performance in Toxins?
a. New Toxin – Dr. Philippe Picaut
b. “Traditional” toxins – Prof. Mark Nestor |
16:21 – 16:33 | AEMOS GMBH – FaceReality, Shaping the Future of Facial Assessment and Treatment Planning with AI
Maris Klepetko, CEO | ||
16:33 – 16:45 | NEXTMOTION
Dr. Emmanuel Elard, Founder | ||
16:45 – 17:00 | Q&A | ||
17:00 – 17:30 | COFFEE BREAK | ||
17:30 – 19:00 | Session 6Regulatory Strategy and Investment Dynamicsin Medical Aesthetic Injectables | 17:30 – 19:00 | Session 13From Battle to Consensus – Part 2 |
|---|---|---|---|
Chair(s): Doug Abel, Laurent Brones, Dr. Michael Gold | Chair(s):Fauad Hasan
Commentators: Dr. Jeremy Green, Natalene Hoepffner, Dr. Marina Landau, Dr. Philippe Picaut | ||
17:30 – 17:35 | Introduction
Doug Abel, Laurent Brones, Dr. Michael Gold | 17:30 – 18:00 | Injection vs other delivery system?
a. Injection – Dr. Thomas Rappl
b. Robotic injection – Dr. Vincent Hunsinger |
17:35 – 18:30 | Part 1 – Regulatory discussion from global authorities | ||
17:35 – 17:43 | How to get your product approved for CE
Melania Battistella, Medical and Regulatory Affairs Consultant
| 18:00 – 18:30 | How to address the adverse events with BTX, is anticolinesteraes a real antidote?
a. Yes – Prof. Mark Nestor
b. No – Mary Gardner |
17:43 – 17:51 | How to get your product approved for FDA
Russ Olsen, HEALTH POLICY ASSOCIATES | 18:30 – 19:00 | Trapezius injection
a. Pro – Dr. Won Lee
b. Con – Dr. Svetlana Larkina |
17:51 – 17:59 | How to get your product approved for KFDA
Yeo Hye Yoon, Director of Regulatory Affairs, JOONGHUN PHARMACEUTICAL | ||
17:59 – 18:07 | How to get your product approved for CDMA
Bin Wu, BEIJING REG-MED | ||
18:07 – 18:22 | – Round table discussion – | ||
Mr. Robert Braithwaite, Private Investor & investor representative, CHANGCHUN SINOBIOMATERIALS (affiliate with NORDBERG BIOMEDICAL in Sweden) | |||
Mr. Frederic Guer, Head of Regulatory, FILLMED LABORATOIRES | |||
Mr. Fred He, Head of Corporate Development, BLOOMAGE BIOTECH (affiliate with REVITACARE in France) | |||
Dr. Hyoung Jin Moon, CEO & CMO, HUGEL (affiliate with BENEV in United States) | |||
18:22 – 18:30 | Q&A | ||
18:30 – 19:00 | Part 2 – Investment from China to Europe and United States in Medical Injectables Development | ||
18:30 – 19:00 | Moderator(s): Jean Yves Coste, Prof. Haiyan Cui
| ||
18:30 – 19:00 | Major Trends in the Chinese Dermal Fillers and Toxin Markets and Regulatory Transformations
Jean Yves Coste, Co-Founder and Chairman, WINDOME BANKING PARTNERS
| ||
18:30 – 19:00 | – Round table discussion – | ||
Mr. Robert Braithwaite, Private Investor & investor representative, CHANGCHUN SINOBIOMATERIALS (affiliate with NORDBERG BIOMEDICAL in Sweden) | |||
Dr. XueKun Jin, CEO and Chairman, SHANXI JINBO BIO-PHARMACEUTICAL | |||
Mr. Fred He, Head of Corporate Development, BLOOMAGE BIOTECH (affiliate with REVITACARE in France) |
Day 2 – Fillers |
|---|
Time | Room 1 | Time | Room 2 |
|---|---|---|---|
09:00 – 10:15 | Session 14
Deep Basic Science – Back to the Future | 09:00 – 10:15 | Session 21
Open communication – Fillers |
Chair(s): Dr. Michael Gold, Dr. Patricia Ogilvie, Prof. Glenn Prestwich | Chair(s): Natalene Hoepffner, Dr. Patrick Treacy | ||
09:00 – 09:15 | Science of HA Crosslinking: Translating Safe and Scalable Products to the Clinic Prof. Glenn Prestwich | 09:00 – 09:10 | Usage of hyaluronic acid fillers and innovative device technology for enhancement of male and female’s genitals
Dr. Jennifer Walden |
09:15 – 09:30 | Rheological Properties and new materials for injectability
Prof. Matteo D’Este | 09:10 – 09:20 | Clinical response to infra-red device treatment in combination with PEGylated dermal filler in a woman with skin laxity on the arms. Case report
Raquel Fernandez de Castro Isalguez |
09:30 – 09:45 | Modified HA for Regenerative Aesthetics
Prof. Chiara Schiraldi | 09:20 – 09:30 | Periorbital Augmentation with Filler
Dr. Jordan Jacobs |
09:45 – 10:00 | Science of Collagen Injectables: Repair and Replacement
Prof. Michael Yu | 09:30 – 09:40 | Occupational Lip Asymmetry Managed by Hyaluronic Acid Fillers
Dr. Ashish Chauhan |
10:00 – 10:15 | Q&A | 09:50 – 10:00 | Poly‑L‑lactic acid body bioplasty
Dr. Victoria Paez Ruiz |
10:00 – 10:10 | Safer Approach in Nonsurgical Rhinoplasty
Dr. Milette Divinagracia-Tio | ||
10:10 – 10:15 | Q&A | ||
10:15 – 10:45 | COFFEE BREAK | ||
10:45 – 12:00 | Session 15Product Analysis | 10:45 – 12:00 | Session22Body fillers injection: what is the limit? |
|---|---|---|---|
Chair(s): Dr. Ting Song Lim, Dr. Thomas Rappl | Chair(s): Dr. Shimon Eckhouse | ||
10:45 – 11:00 | Presentation of the comparative study
Dr. Ting Song Lim, Dr. Thomas Rappl | 10:45 – 11:30 | Part 1 – GLP-1 |
11:00 – 12:00 | – Round table discussion – | 10:45 – 11:00 | GLP-1 impact on face and body
Dr. Jennifer Walden |
Denis Couchourel, Scientific & Medical Director, LABORATOIRES VIVACY
| 11:00 – 11:15 | Is GLP-1 changing aesthetic treatment prescription?
Dr. Shimon Eckhouse | |
Dr. Ferial Fanian, Scientific Director, FILLMED LABORATOIRES | 11:15 – 11:30 | Round table discussion
Moderator: Laura Reveillon | |
Anne Laure Gaudry, Head of Innovation Research & Development, HTL BIOTECHNOLOGY
| Panelist(s): Dr. Rui Avelar, Dr. Svetlana Larkina, Dr. Patrick Treacy | ||
Dr. Albina Kajaia, Managing Partner, Head of Medical and Scientific Departments, APTOS | 11:30 – 12:00 | Part 2 – Body injection fillers: where are we?
Moderator: Dr. Sergio Escobar | |
Dr. Won Lee, JOONGHUN PHARMACEUTICAL | 11:30 – 11:40 | Overview of all body injection fillers in 2024
Dr. Segio Escobar | |
11:40 – 12:00 | – Round table discussion –
Ario Khoshbin, CEO, PROLLENIUM |
12:00 – 13:15 | Session 16Disruptive Innovations in Fillers– Startups – | 12:00 – 13:15 | Session 23Industry Symposium |
|---|---|---|---|
Chair(s): Dr. Per Heden, Dr. Won Lee, Prof. Glenn Prestwich | |||
12:00 – 12:05 | Introduction
Dr. Per Heden, Dr. Won Lee, Prof. Glenn Prestwich | ||
12:05 – 12:13 | AAT
Doug Abel | ||
12:13 – 12:21 | AQPHA MEDICAL – PTMC fillerDr. Monica Rocha, Director Clinical and Medical Affairs | ||
12:21 – 12:29 | HALLURA
Stephane Meunier, CEO | ||
12:29 – 12:37 | KYLYS AESTHETICS – New Crosslinked HA for Adaptable Aesthetics
Bryan Porcello, CEO | ||
12:37 – 12:45 | SUMMADERM – Higher longevity in dermal filler
Haim Dvir, CEO | ||
12:45 – 12:53 | BMG PHARMA – Hyaluromimethic® Technology based lipoate derivatives
Luca Stucchi, CSO | ||
12:53 – 13:01 | MORPHIYA – Regenerative injectable exosome
Dr. Tiryaki Tunc, Chairman, THE MAGE GROUP | ||
13:09 – 13:15 | Q&A | ||
13:15 – 14:30 | LUNCH | ||
14:30 – 15:45 | Session 17Competitive Landscape | 14:30 – 15:30 | Session 24From Battle to Consensus – Part 3A |
|---|---|---|---|
Chair(s): Humberto Antunes, Dr. Benjamin Ascher | Chair(s): Thomas Rappl
Commentators: Dr. Nimrod Friedman, Dr. Po Han Patrick Huang, Dr. Marina Landau, Prof. Mark Nestor, | ||
14:30 – 14:45 | Intro to the market – Quantitative and Qualitative aspect
Laura Reveillon, Partner, BCG | 14:30 – 15:00 | Pre injection aspiration
a. Pro – Dr. Abraham Benzaquen
b. Con – Dr. Frank Rosengaus |
14:45 – 15:20 | Part 1 – Fillers
| 15:00 – 15:30 | Injectable tools needle vs cannula: safety and precision
a. Needle – Dr. Khaled Othman
b. Cannula – Dr. Jeremy Green |
14:45 – 15:20 | – Round table discussion –
| ||
Michel Cheron, CEO LABORATOIRES VIVACY | |||
Dr. Shimon Eckhouse, Chairman ALON MEDTECH VENTURES | |||
Mutlu Erturan, CEO THE MAGE GROUP | |||
Ario Khoshbin, CEO PROLLENIUM | |||
George Sulamanidze, CEO APTOS | |||
15:20 – 15:45 | Part 2 – Fillers Raw Materials | ||
15:20 – 15:45 | – Round table discussion – | ||
Francois Fournier, CEO, HTL BIOTECHNOLOGY | |||
Elana Hariton Gazal, VP Research and Development, COLLPLANT | |||
Darren Hieber, Senior Vice President of Corporate Development and Partnerships, LIFECORE BIOMEDICAL |
15:45 – 17:00 | Session 18Emerging and Pipeline Technologies or indication in Fillers & Toxins | 15:30 – 17:00 | Session 25From Battle to Consensus – Part 3B |
|---|---|---|---|
Chair(s): Dr. Ting Song Lim, Prof. Glenn Prestwich | Chair(s): Thomas Rappl
Commentators: Dr. Nimrod Friedman, Dr. Po Han Patrick Huang, Dr. Marina Landau, Prof. Mark Nestor | ||
15:45 – 15:50 | Introduction
Prof. Glenn Prestwich | 15:30 – 16:00 | Diluting, mixing, and decanting fillers?
a. Pro – Dr. Pierre Andre
b. Con – Dr. Won Lee |
15:50 – 16:05 | SYMATESE – Cold-X Technology
Benjamin Herbage, Deputy Managing Director | 16:00 – 16:30 | Ultrasound-guide injection: is it a real progress?
a. Yes – Dr. Benjamin Ascher
b. No – Dr. Patricia Ogilvie |
16:05 – 16:20 | APTOS – New PLLA filler
Dr. George Sulamanidze, CEO | 16:30 – 17:00 | Vascular compromise (skin necrosis), what is the best protocol?
a. High dose hyaluronidase – Dr. Patrick Treacy
b. Ultrasound-guided hyaluronidase – Dr. Sergio Escobar |
16:20 – 16:35 | COLLPLANT – Photocurable dermal filler
Dr. Elana Hariton Gazel, VP Research and Development | ||
16:35 – 16:50 | SYRHA TECH
Gilles Bos, Founder | ||
16:50 – 17:00 | Q&A | ||
17:00 – 17:30 | COFFEE BREAK | ||
17:30 – 19:00 | Session 19Injectable fireside chat | 17:30 – 19:00 | Session 26From Battle to Consensus – Part 4 |
|---|---|---|---|
Chair(s): Dr. Per Heden, Wendy Lewis, Prof. Mark Nestor | Chair(s): Dr. Ferial Fanian
Comentators: Dr. Abraham Benzaquen, Prof. Haiyan Cui, Dr. Thomas Rappl, Dr. Frank Rosengaus, Dr. Patrick Treacy | ||
17:30 – 17:35
| Introduction
Prof. Mark Nestor | 17:30 – 18:00 | Temporal lifting technique
a. Yes – Dr. Po Han Patrick Huang
b. No – Dr. Marina Landau |
17:35 – 18:00 | Part 1 – Private equity in aesthetic centers acquisition
Moderator: Benoit Chardon | 18:00 – 18:30 | Biostimulators
a. Yes – Dr. Patricia Ogilvie
b. No – Dr. Jeremy Green |
17:35 – 17:40 | Introduction
Benoit Chardon | 18:30 – 19:00 | Delayed Inflammatory Reaction: infection or inflammation?
a. Infection – Dr. Ferial Fanian
b. Inflammation – Dr. Sergio Escobar |
17:40 – 18:00 | – Round table discussion –
Tracy Cohen, CEO, CLINIQUE CLINIQUE DES CHAMPS ELYSEES, France
Jean-Yves Coste, Co-Founder and Chairman, WINDOME BANKING PARTNERS
Dr. Karamveer Singh Chhabra, Executive Director, ALIVE WELLNESS CLINIC, India
Dr. Ben Pask, Founder, RARE GROUP, United Kingdom
Dominic Mazzone, CEO, MEDSPA PARTNERS, Canada
| ||
18:00 – 18:30 | Part 2 – The opportunity of ultrasound-guided injection in the aesthetics space
Moderator: Dr. Benjamin Ascher, Dr. Per Heden | ||
18:00 – 18:10 | Ultrasound-guided injection market data
Raghav Tangri, CETAS HEALTHCARE | ||
18:10 – 18:30 | – Round table discussion –
Dr. Nimrod Friedman
Dr. Diala Haykal | ||
18:30 – 19:00 | Part 3 – Non-physician entrance in the aesthetic medicine profession
Moderator: Wendy Lewis | ||
18:30 – 18:35 | Introduction
Wendy Lewis | ||
18:35 – 19:00 | – Round table discussion –
Dr. Chiranjiv Chhabra
Jean-Yves Coste, Co-Founder and Chairman, WINDOME BANKING PARTNERS
Dr. Nimrod Friedman
| ||
19:00 – 19:30 | Session 20
MAIS Injectables Creator Awards |